Abstract. Sentinel lymph node biopsy (SLNB) is used to determine the pathological status of the first lymph node receiving lymphatic drainage from the primary tumor. The diagnostic value of SLNB for the assessment of the nodal status in patients with cervical cancer has not been determined. Therefore, this meta-analysis was conducted to assess the diagnostic value of SLNB in cervical cancer. A search for related literature was performed using PubMed. Data were analyzed using a random effects model and a subgroup analysis was used to assess the diagnostic value of different practices during the process. A total of 17 studies involving a total of 1,112 patients were included in the analysis. The pooled sentinel lymph node (SLN) detection rate, sensitivity and negative predictive values were 92.2% [95% confidence interval (CI): 88.3-94.8%], 88.8% (95% CI: 85.1-91.7%) and 95.0% (95% CI: 92.8-96.6%), respectively. The subgroup analysis revealed that laparoscopy, tracer combination and immunohistochemistry were associated with a higher SLN detection rate. In conclusion, the SLNB in cervical cancer appears to be of diagnostic value, particularly the procedure with the combination of laparoscopy, combined tracers and immunohistochemistry. However, further studies are required to establish the clinical value of SLNB in cervical cancer.
Introduction
The concept of the sentinel lymph node (SLN) refers to the first lymph node to receive lymphatic drainage from the primary tumor. Sentinel lymph node biopsy (SLNB) is used to determine the local and regional lymph node status of solid tumors. It was first described by Cabanas (1) for the management of penile cancer and has been widely used as an effective regional nodal staging procedure after a 1992 landmark study on melanoma patients (2) . It is currently used in several solid tumors, including breast cancer and melanoma (3, 4) . The application and validity of SLNB in cervical cancer should be practiced with caution, since the lymphatic drainage of the cervix is significantly more complicated, due to its midline position. Although a number of feasibility studies for SLNB in cervical cancer have been conducted, SLNB does not appear to be suitable for clinical application, due to the wide range of reported detection rates, from 55.5 (5) to 100% (6) . A high detection rate may render SLBN in cervical cancer feasible in clinical practice, which may decrease the complications, such as prolonged operation time, blood loss, lymphocyst and lymphedema, experienced by patients undergoing lymph node dissection (7). The pelvic nodal involvement rate in early-stage cervical cancer cases eligible for surgery was reported to be 0-4.8% in stage IA, 17% in stage IB and 12-27% in stage IIA disease (8, 9) , suggesting that lymph node dissection may not be beneficial in >90% of stage IA cases. Therefore, a reliable SLBN is crucial.
There is currently no clear assessment of SLNB diagnostic performance. Therefore, a meta-analysis of the published studies was conducted, with the aim to provide a comprehensive and up-to-date overview of the feasibility and diagnostic value of SLNB in cervical cancer.
Materials and methods
Search strategy. A comprehensive, systematic search for published studies was performed using the search terms 'cervical cancer', 'sentinel lymph node', 'sensitivity' and 'negative predictive value' in the PubMed database, with a time cutoff of September, 2012. The selected articles were limited to the English language. Reviews, comments, letters, conference abstracts and case reports were excluded from this analysis. Publications with a sample size of <10 were also excluded, since they were considered as case reports (10) . The SLNB appears to be a better testing method compared to positron emission tomography, magnetic resonance imaging and computed tomography (11) . Furthermore, surgical resection is the preferred therapeutic method for early cervical cancer. Therefore, we analyzed the studies in which sentinel lymph nodes (SLNs) were detected by the blue dye technique and/or by the use of a radiotracer intraoperatively.
Data extraction. Two independent investigators carefully extracted data from the selected articles using predefined tables, including first author, year of publication, sample size, route of surgery, detection method, type of pathological assessment and diagnostic results (detection rate, mean SLN number, bilateral detection rate, sensitivity and negative predictive value).
Statistical analysis. The detection rate, sensitivity and negative predictive values were pooled with the random effects model of DerSimonian and Laird (13), using MetaAnalyst Beta 3.13 software (Tufts Medical Center, Boston, MA, USA) (12) . The potential heterogeneity among the studies was assessed using the Q-statistic and P<0.1 was considered to indicate a statistically significant difference. If heterogeneity was present, a subgroup analysis was used for further assessment.
Results

Study selection and description.
A total of 38 studies were identified with the established search strategy. Studies that were clearly not eligible, as indicated by the information provided in the abstract, were excluded. For the remaining studies, the full text was read. Finally, a total of 17 studies were included in the analysis, involving a total of 1,112 patients (5, 6, (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . The study selection process is summarized in Fig. 1 . The median number of included patients per study was 50 (range, 12-211). The detailed characteristics of the 17 eligible studies are summarized in Table I and the diagnostic performance of SLNB is summarized in Table II. Analysis of the 17 studies. The diagnostic value of SLNB was affected by several factors and significant heterogeneity was identified (Table I) . Therefore, data were pooled using a random effects model.
The pooled detection rate of SLN was 92.2% (95% CI: 88.3-94.8%; Fig. 2 ), whereas the pooled sensitivity and negative predictive values were 88.8 and 95.0%, respectively ( Fig. 3A and B) . When considering the detection method, the pooled SLN detection rate in dye subgroup (2 studies), the isotope subgroup (4 studies) and the combination of the two subgroup (11 studies) was 87.5, 90.3 and 94.3%, respectively. The pooled negative predictive value of the combination subgroup was higher compared to that of the dye and isotope subgroups.
When considering the pathological assessment type, the pooled detection rates in the HE+IHC subgroup (12 studies) was 93.1% and in the HE subgroup 89.4% (4 studies).
Discussion
In the present meta-analysis we pooled the detection rate, sensitivity and negative predictive values with data extracted from 17 studies. The overall SLN detection rate was 92.2%, which was satisfactory in the SLNB of cervical cancer, whereas the high pooled sensitivity (88.8%) and negative predictive values (95.0%) also indicated that this procedure is feasible.
However, the diagnostic parameters were affected by several factors, such as the route of surgery, the detection method, the pathological assessment type and other predictable/unpredictable factors. Subgroup analyses were performed for the three factors mentioned above.
First, in the subgroup analysis according to the route of surgery, we observed that the detection rate of laparoscopy was superior to that of laparotomy (96.1 vs. 90.2%). Furthermore, laparoscopy exhibited a higher sensitivity compared to laparotomy (89.8 vs. 86.3%), with wide visual fields and minimal incisions. Therefore, the technologically improved laparoscopic equipment is recommended for the surgical treatment of cervical cancer.
Second, the SLN detection rate in cervical cancer with the combination of dye and isotope (94.3%) was higher compared to that of dye (87.5%) or isotope (90.3%) alone. In addition, the pooled negative predictive value exhibited the same trend. Van de Lande et al (29) also reported that the combination of a radionuclide with a blue dye was the optimal method of SLN detection in a systematic review that mainly compared the three methods.
Finally, when the pathological assessment with HE + IHC was used to determine the lymph node status, higher detection and sensitivity rates were achieved compared to the HE group (93.1 vs. 89.4% and 89.6 vs. 88.0%, respectively). IHC may accurately determine the lymph node status, since it is able to detect micrometastases, compared to HE alone (30) . Therefore, under the appropriate conditions, IHC is recommended in SLNB.
In this meta-analysis, the predetermined search strategy described above was used for the selection of studies from the available literature. Several studies on SLNB in cervical cancer were identified; however, the data used by each study to describe the performance characteristics were inconsistent, due to the different objectives of the studies. Several studies reported data that were not sufficient to calculate sensitivity or negative predictive values, leading to the exclusion of those studies.
Furthermore, in view of the limited time and capacity, newly published literature was not included in our study.
In conclusion, we analyzed the performance characteristics of SLNB in cervical cancer using data from 17 studies, including a total of 1,112 patients. Although SLNB appears to exhibit a satisfactory diagnostic performance in the meta-analysis, further studies are required to determine the true performance of the clinical application of SLNB in cervical cancer. 
